Huons Global Co., Ltd. (084110.KQ)
KRW 48550.0
(3.41%)
KRW 48550.0
(3.41%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 417.8 Billion KRW | 14.57% |
| 2022 | 360.13 Billion KRW | 13.11% |
| 2021 | 318.38 Billion KRW | 10.77% |
| 2020 | 287.43 Billion KRW | 13.4% |
| 2019 | 253.47 Billion KRW | 14.08% |
| 2018 | 222.18 Billion KRW | 14.03% |
| 2017 | 194.84 Billion KRW | 121.37% |
| 2016 | 88.02 Billion KRW | 215.86% |
| 2015 | 27.86 Billion KRW | -70.43% |
| 2014 | 94.24 Billion KRW | 20.31% |
| 2013 | 78.33 Billion KRW | 23.77% |
| 2012 | 63.28 Billion KRW | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 114.97 Billion KRW | 10.37% |
| 2024 Q1 | 105.49 Billion KRW | 2.61% |
| 2023 FY | 412.61 Billion KRW | 14.57% |
| 2023 Q1 | 96.43 Billion KRW | 2.63% |
| 2023 Q4 | 102.81 Billion KRW | -1.69% |
| 2023 Q2 | 108.83 Billion KRW | 12.86% |
| 2023 Q3 | 104.57 Billion KRW | -3.91% |
| 2022 Q4 | 93.96 Billion KRW | 5.03% |
| 2022 Q1 | 86.53 Billion KRW | 3.52% |
| 2022 FY | 360.13 Billion KRW | 13.11% |
| 2022 Q2 | 90.17 Billion KRW | 4.2% |
| 2022 Q3 | 89.46 Billion KRW | -0.78% |
| 2021 Q1 | 72.91 Billion KRW | -4.23% |
| 2021 Q2 | 81.88 Billion KRW | 12.3% |
| 2021 Q3 | 79.65 Billion KRW | -2.73% |
| 2021 Q4 | 83.59 Billion KRW | 4.95% |
| 2021 FY | 318.38 Billion KRW | 10.77% |
| 2020 Q2 | 72.73 Billion KRW | 11.07% |
| 2020 Q3 | 76.39 Billion KRW | 5.04% |
| 2020 Q4 | 76.14 Billion KRW | -0.33% |
| 2020 Q1 | 65.48 Billion KRW | -6.5% |
| 2020 FY | 287.43 Billion KRW | 13.4% |
| 2019 Q4 | 70.04 Billion KRW | 6.44% |
| 2019 Q3 | 65.8 Billion KRW | 8.6% |
| 2019 Q2 | 60.58 Billion KRW | 2.03% |
| 2019 Q1 | 59.38 Billion KRW | 7.43% |
| 2019 FY | 253.47 Billion KRW | 14.08% |
| 2018 FY | 222.18 Billion KRW | 14.03% |
| 2018 Q4 | 55.27 Billion KRW | -7.35% |
| 2018 Q3 | 59.66 Billion KRW | 6.48% |
| 2018 Q2 | 56.03 Billion KRW | 7.73% |
| 2018 Q1 | 52.01 Billion KRW | -0.53% |
| 2017 Q4 | 52.28 Billion KRW | 2.59% |
| 2017 Q1 | 43.33 Billion KRW | 2.85% |
| 2017 Q2 | 48.26 Billion KRW | 11.38% |
| 2017 Q3 | 50.97 Billion KRW | 5.6% |
| 2017 FY | 194.84 Billion KRW | 121.37% |
| 2016 Q2 | 10.04 Billion KRW | 32.41% |
| 2016 Q4 | 42.13 Billion KRW | 47.74% |
| 2016 Q3 | 28.51 Billion KRW | 183.89% |
| 2016 Q1 | 7.58 Billion KRW | 1.43% |
| 2016 FY | 88.02 Billion KRW | 215.86% |
| 2015 Q2 | 7.34 Billion KRW | 40.34% |
| 2015 Q4 | 7.47 Billion KRW | -7.59% |
| 2015 Q3 | 8.09 Billion KRW | 10.16% |
| 2015 FY | 27.86 Billion KRW | -70.43% |
| 2015 Q1 | 5.23 Billion KRW | -80.47% |
| 2014 Q3 | 24.18 Billion KRW | 6.25% |
| 2014 Q1 | 20.48 Billion KRW | -3.61% |
| 2014 Q2 | 22.76 Billion KRW | 11.1% |
| 2014 Q4 | 26.8 Billion KRW | 10.86% |
| 2014 FY | 94.24 Billion KRW | 20.31% |
| 2013 Q2 | 19.55 Billion KRW | 20.32% |
| 2013 FY | 78.33 Billion KRW | 23.77% |
| 2013 Q1 | 16.25 Billion KRW | 2.65% |
| 2013 Q3 | 21.26 Billion KRW | 8.7% |
| 2013 Q4 | 21.25 Billion KRW | -0.04% |
| 2012 FY | 63.28 Billion KRW | 0.0% |
| 2012 Q4 | 15.83 Billion KRW | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| HLB Pharmaceutical Co., Ltd | 82.98 Billion KRW | -403.467% |
| CMG Pharmaceutical Co., Ltd. | 43.7 Billion KRW | -856.012% |
| Celltrion Pharm, Inc. | 116.95 Billion KRW | -257.219% |
| DongKook Pharmaceutical Co., Ltd. | 405.04 Billion KRW | -3.151% |
| Enzychem Lifesciences Corporation | 3.29 Billion KRW | -12585.718% |
| Humedix Co., Ltd. | 68.04 Billion KRW | -514.012% |
| Boditech Med Inc. | 76.7 Billion KRW | -444.688% |
| EuBiologics Co., Ltd. | 32.65 Billion KRW | -1179.286% |
| FutureChem Co.,Ltd | 758.27 Million KRW | -54999.44% |
| Huons Co., Ltd. | 285.93 Billion KRW | -46.116% |
| BNC Korea Co., Ltd. | 31.97 Billion KRW | -1206.53% |
| AptaBio Therapeutics Inc. | 78.49 Million KRW | -532141.156% |